Nucala

Nucala Description

mepolizumab

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Mepolizumab is a humanised monoclonal antibody (IgG1, kappa), directed against human interleukin-5 (IL-5) produced in Chinese hamster ovary cells by recombinant DNA technology.
NUCALA is supplied as a sterile lyophilised powder for subcutaneous injection after reconstitution. Upon reconstitution with 1.2 mL of Sterile Water for Injection, the resulting concentration is 100 mg/mL and delivers 1 mL, with a pH of 7.0.
Excipients/Inactive Ingredients: Sucrose, Sodium phosphate dibasic heptahydrate, Polysorbate 80, Hydrochloric acid.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in